Global Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2021


Posted October 26, 2016 by globalinforesearchma

APEG is a kind of main raw material for producing high performance polycarboxylate water reducing agent, it is produced with allyl alcohol and ethylene epoxide as raw materials.
 
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.

Published by: GIR (GlobalInfoResearch)
Catalog: Pharmaceutical
Publishing Date: Oct 2016
Single User License: USD 3480
Corporate Users License: USD 4680
Delivery time: 24 hours
Pages: 115
Tables and Figures: 138

Full information :[url]http://www.globalinforesearch.com/goods.php?id=1220[url]

Scope of the Report:

This report focuses on the Biosimilars in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddy’s Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics?
Merck KGaA

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle East and Africa

Market Segment by Type, covers
Injection
Tablets
Others

Market Segment by Applications, can be divided into
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular

There are 13 Chapters to deeply display the global Biosimilars market.

Chapter 1, to describe Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biosimilars, with sales, revenue, and price of Biosimilars, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilars, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Biosimilars sales channel, distributors, traders, dealers, appendix and data source.

Betty
Sales Director
E-mail:[email protected]
Tel: HK:00852-58197708 USA:0013479661888
Add: Room 1902 Two International Finance Centre 8 Finance Street, Central Hong Kong
Website: http://www.globalinforesearch.com/goods_all.php
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Globalinforesearch
Country Hong Kong SAR
Categories Business , Consumer , Research
Last Updated October 26, 2016